Announced Fri, 24 Jul · 17:26 IST
Board meeting on July 31 to consider Q1 FY27 results
Results View source PDF
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹1021.00
prior close
₹1022.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.9+1.1+1.4+1.0——————————
Up moveDown movePending
AI summary
Strides Pharma Science has informed BSE that its Board of Directors will meet on Friday, July 31, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026, along with other matters. The trading window for designated persons is already closed from July 1, 2026 and will reopen 48 hours after results are declared.
Likely market impact
Routine board meeting intimation; investors should watch for Q1 FY27 results on July 31, which may move the stock.